MARK TROTT: Open Payments
NPI 1205892924 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,580 in 64 payments from 12 companies in 2025. Trend: 2023 $1,480 · 2024 $1,727 · 2025 $1,580
Food & beverage: $1,485Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $552 |
| ABBVIE INC. | 21 | $393 |
| GENZYME CORPORATION | 5 | $165 |
| PFIZER INC. | 4 | $114 |
| Incyte Corporation | 3 | $88 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $43 |
| Galderma Laboratories, L.P. | 2 | $36 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, CIBINQO, OPZELURA, Sotyktu, Winlevi.
Industry payments across RI — which companies pay providers there.
